Showing results (631-640 of 12,110) with videos related to
Sort By:
Pageof 1,211
Neuropharmacology|August 30, 2021
Danger and distress: Parabrachial-extended amygdala circuitsA A Jaramillo, J A Brown, D G WinderNeuropharmacology|September 2, 2021
Zonisamide attenuates the severity of levodopa-induced dyskinesia via modulation of the striatal serotonergic system in a rat model of Parkinson's diseaseRie Tohge, Satoshi Kaneko, Satoshi Morise, et al.Neuropharmacology|September 20, 2021
Low molecular weight chondroitin sulfate ameliorates pathological changes in 5XFAD mice by improving various functions in the brainNa Zhao, Lidan Wu, Xinke Zhang, et al.Neuropharmacology|August 10, 2021
Prenatal fluoxetine impairs non-hippocampal but not hippocampal memory in adult male rat offspringRodrigo Moraga-Amaro, Raul Díaz-Galarce, Juan P Donoso-Ramos, et al.Neuropharmacology|August 14, 2021
Circuit and neuropeptide mechanisms of the paraventricular thalamus across stages of alcohol and drug useMatthew C Hartmann, Kristen E PleilNeuropharmacology|August 14, 2021
Effects of a novel M4 muscarinic positive allosteric modulator on behavior and cognitive deficits relevant to Alzheimer's disease and schizophrenia in rhesus monkeyHenry S Lange, Joshua D Vardigan, Christopher E Cannon, et al.Neuropharmacology|April 27, 2020
Acute vitamin B12 supplementation evokes antidepressant response and alters Ntrk-2Charlotte Trautmann, Andrea Bock, Anja Urbach, et al.Neuropharmacology|May 15, 2020
Antidepressive properties of macrophage-colony stimulating factor in a mouse model of depression induced by chronic unpredictable stressTing Ye, Dan Wang, Zixuan Cai, et al.Neuropharmacology|May 8, 2020
Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's diseaseAlok Joshi, Da-Hui Wang, Steven Watterson, et al.Neuropharmacology|May 12, 2020
Negative allosteric modulation of GluN1/GluN3 NMDA receptorsZongjian Zhu, Feng Yi, Matthew P Epplin, et al.Pageof 1,211